Invitation for Proposals under Framework Agreement 2024/1051 - Implantable Cardioverter Defibrillators and Pacemakers, for the acquisition of Implantable Cardioverter Defibrillators

This tender is an invitation for proposals specifically for the acquisition of Implantable Cardioverter Defibrillators (ICDs). It operates under Framework Agreement 2024/1051, which broadly covers both ICDs and Pacemakers. This specific call focuses solely on the ICD component. ICDs are crucial medical devices implanted in patients at high risk of sudden cardiac arrest due to life-threatening arrhythmias. They monitor the heart rhythm and deliver electrical therapy (shocks or pacing) to restore a normal heartbeat. The framework agreement suggests that suppliers for these devices have already been selected through a prior competitive process. This invitation is likely to solicit specific orders or quantities of ICDs from these pre-approved suppliers. The tender aims to ensure the availability of these life-saving devices for patients requiring them. The procurement is linked to the year 2024/2025, indicating a need for these devices within this timeframe. The procuring entity is likely a healthcare provider, hospital, or national health service responsible for patient care and medical device procurement.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 5,420.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.